期刊文献+

外周血单个核细胞TMEVPG1、NRON的表达与精神分裂症患者症状和认知功能的关系 被引量:3

The relationship between the expression of TMEVPG1 and NRON in peripheral blood mononuclear cells and the symptoms and cognitive function of schizophrenia
下载PDF
导出
摘要 目的探讨外周血单个核细胞长链非编码RNA TMEVPG1、NRON的表达水平与精神分裂症患者症状和认知功能的关系。方法用荧光定量PCR法检测68例首发未服药精神分裂症患者(精神分裂症组)和50例健康人(对照组)外周血单个核细胞TMEVPG1、NRON的表达水平。采用阳性与阴性症状量表(PANSS)评价症状严重程度;MATRICS公认认知成套测验(MCCB)评价认知功能。结果精神分裂症组TMEVPG1、NRON的相对表达量分别为(4.80±1.12)和(3.14±1.24),对照组分别为(2.06±0.89)和(1.67±0.73),组间比较差异均有统计学意义(P<0.01)。TMEVPG1、NRON诊断精神分裂症的受试者工作特征曲线下面积(AUC)分别为0.801和0.719,灵敏度分别为80.56%和72.95%,特异度分别为73.33%和81.10%,两者联合检测可将AUC提高至0.854。与对照组比较,精神分裂症组信息处理加工速度、注意警觉性、工作记忆、言语学习、视觉学习、推理问题解决和社会认知均较差(P<0.01)。TMEVPG1和NRON水平均与PANSS量表阴性症状评分和总分呈正相关(r分别为0.480和0.370,P<0.05)。TMEVPG1与精神分裂症患者信息处理加工速度和工作记忆呈负相关(r分别为-0.321和-0.402,P<0.05),NRON水平与注意警觉性呈负相关(r=-0.341,P<0.05)。结论外周血单个核细胞TMEVPG1、NRON的表达与精神分裂症患者的阴性症状及认知功能有关。 Objective To investigatethe relationship between the expression of TMEVPG1 and NRON in peripheral blood mononuclear cells and the symptoms and cognitive function of schizophrenia.Methods The expression of TMEVPG1 and NRON in peripheral blood mononuclear cells of 68 patients(schizophrenia group)and 50 healthy people(control group)were detected by fluorescent quantitative PCR.PANSS and MCCB were used to evaluate the severity of symptoms and MATRICS consensus cognitive battery(MCCB)was used to evaluate the cognitive function.Results The relative expression of TMEVPG1 and NRON were(4.80±1.12)and(3.14±1.24)in schizophrenia group,and(2.06±0.89)and(1.67±0.73)in control group,respectively.There was significant difference between the two groups(P<0.01).The area under the receiver operating characteristic curve(AUC)of TMEVPG1 and NRON in the diagnosis of schizophrenia were 0.801 and 0.719,respectively.The sensitivity was 80.56%and 72.95%,and the specificity was 73.33%and 81.10%,respectively.The AUC of the combined detection of TMEVPG1 and NRON was increased to 0.854.Compared with the control group,the speed of information processing,attention alertness,working memory,speech learning,visual learning,reasoning problem-solving and social cognition of schizophrenia group were worse(P<0.05).TMEVPG1 and NRON were positively correlated with PANSS negative symptom score and total score(r=0.480 and 0.370,respectively,P<0.05).TMEVPG1 was negatively correlated with information processing speed and working memory in schizophrenics(r=-0.321 and-0.402,respectively,P<0.05).And NRON was negatively correlated with attention alertness(r=-0.341,P<0.05).Conclusion The expression of TMEVPG1 and NRON in peripheral blood mononuclear cells is related to the negative symptoms and cognitive function of patients with schizophrenia.
作者 祁娜 白田妹 徐天朝 QI Na;BAI Tian-mei;XU Tian-chao(Department of Psychology,General Hospital of Northen Theater Command,Shenyang 110016,Liaoning,China;Department of Obstetrics and Gynecology,General Hospital of Northen Theater Command,Shenyang 110016,Liaoning,China)
出处 《东南国防医药》 2022年第2期152-156,共5页 Military Medical Journal of Southeast China
关键词 精神分裂症 外周血 长链非编码RNA 认知功能 schizophrenia peripheral blood long-chain non coding RNA cognitive function
  • 相关文献

参考文献6

二级参考文献29

  • 1张本,王丰,王学义,陆林,吴寿岭,周永,王静,王克强,马启民,陶钧,刘文勇,张武文.精神分裂症患者伴发代谢综合征的相关因素[J].中国心理卫生杂志,2006,20(10):661-664. 被引量:25
  • 2De Heft M, Detraux J, van Winkel R, et al. Metabolic and cardio- vascular adverse effects associated with antipsychotic drugs [ J ]. Nat Rev Endocrinol, 2012,8(2) : 114-126.
  • 3Polyzos SA, Kountouras J, Zavos C, et al. The potential adverse role of leptin resistance in nonalcoholic fatty liver disease : a hypothesis based on critical review of the literature [ J]. J Clin Gastroenterol, 2011, 45(1) : 50-54.
  • 4Mercer RE, Chee MJ, Colmers WF. The role of NPY in hypothalamic mediated food intake [ J 1. Front Neuroendocrinol, 2011,32(4) :398-415.
  • 5Pramyothin P,Khaodhiar L. Metabolic syndrome with the atypical antipsychotics [ J]. Curt Opin Endocrinol Diabetes Obes, 2010, 17(5) : 460-466.
  • 6Das C, Mendez G, Jagasia S, et al. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysisof behavioral and pharmacologic treatments [ J ]. Ann Clin Psychiatry, 2012, 24(3) : 225-239.
  • 7Me Evoy JP, Meyer JM, Goff DC, et al.Prevalence of the metabolic syndrome in patients with schizophrenia:baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANESIII [ J ].Schizophr Res, 2005,80 ( 1 ) : 19-32.
  • 8Wu RR, Zhao JP, Liu ZN, et al.Effects of typical and atypical anti- psychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia[J]. Psychopharmacology(Berl) ,2006, 186(4) :572-578.
  • 9Lamberti JS,Olson D, Cri|ly JF, et al. Prevalence of the metabolic syndrome among patients receiving clozapine [ J ] .Am J Psychiatry, 2006,163(7) : 1273-1276.
  • 10Reynolds GP, Kirk SL. Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms [ J ]. Pharmacol Ther, 2010, 125 ( 1 ) : 169-179.

共引文献747

同被引文献25

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部